References
- Scharberg EA, Olsen C, Bugert P. The H blood group system. Immunohematology 2016;32:112–8.
- Daniels G. Human blood groups. Oxford, U.K.: Blackwell Scientific, 2002.
- Spitalnik PF, Spitalnik SL. The P blood group system: biochemical, serological, and clinical aspects. Transfus Med Rev 1995;9:110–22.
- Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006;46:630–5.
- Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009;49:453–7.
- Hellberg A, Poole J, Olsson ML. Molecular basis of the Globoside-deficient Pk blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene. J Biol Chem 2002;277: 29455–9.
- Cedergren B. Population studies in northern Sweden. IV. Frequency of the blood type P. Hereditas 1973;73:27–30.
- Daniels GL, Fletcher A, Garratty G, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004;87:304–16.
- Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ. Human blood groups: incidental receptors for viruses and bacteria. J Transfus 1996;36:362–74.
- Lindström K, Von Dem Borne AE, Breimer ME, et al. Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women: evidence for placenta being the primary target for anti-Tja-antibodies. Glycoconj J 1992;9:325–9.
- Hagman JR, Hult AK, Westman JS, et al. Multiple miscarriages in two sisters of Thai origin with the rare Pk phenotype caused by a novel nonsense mutation at the B3GALNT1 locus. Transfus Med 2019;29:202–8.
- Prince SD, Winestone LE, Nance SJ, Friedman DF. Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report. Transfusion 2017;57:1401–6.
- Westman JS, Benktander J, Storry JR, et al. Identification of the molecular and genetic basis of PX2, a glycosphingolipid blood group antigen lacking on globoside-deficient erythrocytes. J Biol Chem 2015;290:18505–18.
- Chang A, Kim Y, Hoehn R, Jernigan, Pritts T. Cryopreserved packed red blood cells in surgical patients: past, present, and future. Blood Transfus 2017;15:341–7.
- Cap A, Badloe J, Woolley T, et al. The use of frozen and deglycerolized red blood cells. Mil Med 2018;18:10–52.
- Mastellos DC, Ricklin D, Lambris JD. Clinical promise of next-generation complement therapeutics. Nature Rev Drug Discov 2019;18:707–29.
- Franchini M, Marano G, Veropalumbo E, et al. Patient blood management: a revolutionary approach to transfusion medicine. Blood Transfus 2019;17:191–5.
- Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017;57:1347–58.